Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14251 - 14275 of 14795 in total
Experimental
Cloridarol is an experimental medication in the treatment of heart disease, which acts through vasodilation. It was studied for the treatment of coronary insufficiency in Italy in the 1970s .
Experimental
Matched Description: … It was studied for the treatment of coronary insufficiency in Italy in the 1970s [A176222]. ... Cloridarol is an experimental medication in the treatment of heart disease, which acts through vasodilation …
R1204 is G-protein-coupled receptor modulator. It is developed for the treatment of depression.
Investigational
Matched Description: … It is developed for the treatment of depression. …
Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers).
Investigational
Matched Description: … Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers …
KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.
Experimental
Matched Description: … KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.[L43822] …
KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2).
Investigational
Matched Description: … KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2). …
Experimental
Illicit
Experimental
Tmi 005 is under investigation in clinical trial NCT00095342 (Study Evaluating TMI-005 in Active Rheumatoid Arthritis).
Investigational
Experimental
ATL146e is an anti-inflammatory compounds which is an agonist of A2A adenosine receptors.
Investigational
Matched Description: … ATL146e is an anti-inflammatory compounds which is an agonist of A2A adenosine receptors. …
Tulobuterol has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.
Investigational
Matched Description: … Tulobuterol has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease. …
Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.
Investigational
Matched Description: … Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease. …
NLX-P101, gene therapy is developed by Neurologix to treat Parkinson’s disease. The gene is glutamic acid decarboxylase (GAD), whose product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and targets the subthalamic nucleus (STN), which is overactive in patients with Parkinson’s disease. NLX-P101 is being evaluated as...
Investigational
Matched Description: … product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and
Experimental
Illicit
Displaying drugs 14251 - 14275 of 14795 in total